84512-08-3Cl.O=C(O)CCCC1CCNCC1UTPNREIRALGKPW-UHFFFAOYSA-N84512-08-3DTXSID50584224化学的特性white crystalline solid
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
使用Reactant for: Modification of 3-amidinophenylalanine-derived matriptase inhibitors Reactions between Weinreb amides and 2-magnesiated oxazoles Reactant for synthesis of: NAmPRTase inhibitors FK866 analogs for NAD salvage inhibition
一般的な説明4-Piperidine butyric acid hydrochloride participates in the synthesis of FK866 [(E)-N-[4-(1-benzoylpiperidin-4-yl)butyl]-3-(pyridin-3-yl)acrylamide], an inhibitor of NAD biosynthesis.
読み込み中…